Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EYPT
EYPT logo

EYPT News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

EYPT News

EyePoint Sues Ocular for False Claims on Duravyu

Mar 21 2026seekingalpha

EYEPOINT INC - SEC Filing Claims Ocular Therapeutix Made False Statements About EYEPOINT and DURAVYU

Mar 20 2026moomoo

Parkman Healthcare Partners Acquires New Stake in EyePoint Pharmaceuticals

Mar 16 2026Fool

Parkman Acquires New Stake in EyePoint

Mar 16 2026NASDAQ.COM

Wall Street Analysts Adjust Ratings

Mar 05 2026Benzinga

EyePoint, Inc. Q4 2025 Earnings Call Insights

Mar 04 2026seekingalpha

EyePoint Pharmaceuticals Q4 Earnings Miss Expectations

Mar 04 2026seekingalpha

EyePoint Pharmaceuticals to Announce Q4 Earnings on March 4

Mar 03 2026seekingalpha

EYPT Events

03/16 07:20
EyePoint Grants 20,000 Stock Options to New Employees
EyePoint granted non-statutory stock options to new employees as inducement awards outside the Company's 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an aggregate of 20,000 shares of EyePoint common stock to six new employees. The stock options were granted on March 13, 2026. The grants were approved by the Compensation Committee and made as an inducement material to each employee entering into employment with EyePoint in accordance with NASDAQ Listing Rule 5635(c)(4). The option awards have an exercise price of $13.20 per share, the closing price of EyePoint's common stock on March 13, 2026. The options have a ten-year term and vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employee's date of grant and the remainder vesting in equal monthly installments over the following three years. Vesting of the options is subject to the employee's continued service with EyePoint through the applicable vesting dates.

EYPT Monitor News

EyePoint Inc stock rises after crossing above 5-day SMA

Feb 17 2026

EYPT Earnings Analysis

No Data

No Data

People Also Watch